Optimization of ultracentrifugation-based method to enhance the purity and proteomic profiling depth of plasma-derived extracellular vesicles and particles.

biomarkers early cancer detection extracellular vesicles and particles (EVPs) proteomics

Journal

Journal of extracellular biology
ISSN: 2768-2811
Titre abrégé: J Extracell Biol
Pays: United States
ID NLM: 9918382980506676

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 30 06 2023
revised: 25 06 2024
accepted: 02 07 2024
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 24 7 2024
Statut: epublish

Résumé

Circulating extracellular vesicles and particles (EVPs) are being investigated as potential biomarkers for early cancer detection, prognosis, and disease monitoring. However, the suboptimal purity of EVPs isolated from peripheral blood plasma has posed a challenge of in-depth analysis of the EVP proteome. Here, we compared the effectiveness of different methods for isolating EVPs from healthy donor plasma, including ultracentrifugation (UC)-based protocols, phosphatidylserine-Tim4 interaction-based affinity capture (referred to as "PS"), and several commercial kits. Modified UC methods with an additional UC washing or size exclusion chromatography step substantially improved EVP purity and enabled the detection of additional proteins via proteomic mass spectrometry, including many plasma membrane and cytoplasmic proteins involved in vesicular regulation pathways. This improved performance was reproduced in cancer patient plasma specimens, resulting in the identification of a greater number of differentially expressed EVP proteins, thus expanding the range of potential biomarker candidates. However, PS and other commercial kits did not outperform UC-based methods in improving plasma EVP purity. PS yielded abundant contaminating proteins and a biased enrichment for specific EVP subsets, thus unsuitable for proteomic profiling of plasma EVPs. Therefore, we have optimized UC-based protocols for circulating EVP isolation, which enable further in-depth proteomic analysis for biomarker discovery.

Identifiants

pubmed: 39045341
doi: 10.1002/jex2.167
pii: JEX2167
pmc: PMC11263976
doi:

Banques de données

figshare
['10.6084/m9.figshare.22798619']

Types de publication

Journal Article

Langues

eng

Pagination

e167

Informations de copyright

© 2024 The Author(s). Journal of Extracellular Biology published by Wiley Periodicals LLC on behalf of International Society for Extracellular Vesicles.

Déclaration de conflit d'intérêts

The authors declare conflicts of interest.

Auteurs

Zurong Wan (Z)

Drukier Institute of Children's Health Weill Cornell Medicine New York New York USA.
Department of Pediatrics Weill Cornell Medicine New York New York USA.

Jinghua Gu (J)

Drukier Institute of Children's Health Weill Cornell Medicine New York New York USA.
Department of Pediatrics Weill Cornell Medicine New York New York USA.

Uthra Balaji (U)

Drukier Institute of Children's Health Weill Cornell Medicine New York New York USA.
Department of Pediatrics Weill Cornell Medicine New York New York USA.

Linda Bojmar (L)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Meyer Cancer Center Weill Cornell Medicine New York New York USA.
Department of Clinical and Experimental Medicine Linköping University Linköping Sweden.

Henrik Molina (H)

Proteomics Resource Center The Rockefeller University New York New York USA.

Søren Heissel (S)

Proteomics Resource Center The Rockefeller University New York New York USA.

Alexandra E Pagano (AE)

Proteomics Resource Center The Rockefeller University New York New York USA.

Christopher Peralta (C)

Proteomics Resource Center The Rockefeller University New York New York USA.

Lee Shaashua (L)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Meyer Cancer Center Weill Cornell Medicine New York New York USA.

Dorina Ismailgeci (D)

Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.

Hope K Narozniak (HK)

Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.

Yi Song (Y)

Hepatopancreatobiliary Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA.

William R Jarnagin (WR)

Hepatopancreatobiliary Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York New York USA.

David P Kelsen (DP)

Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.

Jaqueline Bromberg (J)

Department of Medicine Memorial Sloan Kettering Cancer Center New York New York USA.
Department of Medicine Weill Cornell Medicine New York New York USA.

Virginia Pascual (V)

Drukier Institute of Children's Health Weill Cornell Medicine New York New York USA.
Department of Pediatrics Weill Cornell Medicine New York New York USA.

Haiying Zhang (H)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Meyer Cancer Center Weill Cornell Medicine New York New York USA.

Classifications MeSH